Diabetes Increases the Number of Eye Disease Patients at Risk for Blindness

09:35 EDT 28 Oct 2019 | PR Web

Prevent Blindness Offers New Informational Resource for November’s Diabetes-related Eye Disease Awareness Month

CHICAGO (PRWEB) October 28, 2019

According to the new “World Report on Vision” from the World Health Organization, the number of people with diabetes-related retinopathy globally is estimated to increase from 146 million in 2014 to 180.6 million in 2030. And, according to the Centers for Disease Control and Prevention, diabetes is the leading cause of new cases of blindness in adults in the United States.

Prevent Blindness, the nation’s oldest volunteer eye health non-profit organization, has declared November as Diabetes-related Eye Disease Awareness Month to educate the public on the effects of diabetes on vision, risk factors, and treatment options.

Prevent Blindness recently launched a new, no-cost resource, the “Diabetes and the Eyes” educational toolkit. The resource includes downloadable fact sheets, shareable infographics for social media, and financial assistance resources to increase access to eye care. For healthcare professionals, community organizers, and more, an educator course is also available, including a PowerPoint presentation and script. These materials were made possible by funding from the Allergan Foundation.

Diabetes-related eye disease refers to a group of eye problems that people with diabetes may face as a complication of the disease including diabetes-related retinopathy and diabetes-related macular edema (DME). Those with diabetes are also at greater risk for cataract and glaucoma.

People with diabetes may lower their risk of developing eye disease by:

  • Knowing their numbers to manage glucose, blood pressure, and cholesterol levels.
  • Getting a dilated eye exam annually, or more often, as recommended by an eye doctor.
  • Maintaining a healthy lifestyle, including regular exercise, not smoking, and following a healthy meal plan.

For the second consecutive year, Oxurion NV, a biopharmaceutical company developing innovative treatments to preserve vision in patients with diabetes-related eye disease, is partnering with Prevent Blindness to raise awareness and provide education to the public as part of for November’s Diabetes-related Eye Disease month.

“The longer someone has diabetes, the higher the risk for diabetes-related eye disease,” said Jeff Todd, president and CEO of Prevent Blindness. “It is imperative that people with diabetes work closely with their eye doctor to take the necessary steps to help prevent significant vision loss.”

For more information on diabetes-related eye disease, please visit, or call Prevent Blindness at (800) 331-2020 or visit For a free listing of organizations and services that provide financial assistance for vision care in English or Spanish, please visit

About Prevent Blindness
Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public.

Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, or to make a contribution to the sight-saving fund, call (800) 331-2020. Or, visit us on the Web at or

For the original version on PRWeb visit:


More From BioPortfolio on "Diabetes Increases the Number of Eye Disease Patients at Risk for Blindness"

Quick Search